Pediatric Gastroenterology, Hepatology and Nutrition, Emma Children's Hospital, Amsterdam University Medical Centers University of Amsterdam, Amsterdam, The Netherlands.
Pediatric Immunology, Rheumatology and Infectious Disease, Emma Children's Hospital, Amsterdam University Medical Centers University of Amsterdam, Amsterdam, The Netherlands.
JPEN J Parenter Enteral Nutr. 2024 May;48(4):486-494. doi: 10.1002/jpen.2630. Epub 2024 Apr 11.
Children with chronic IF require long-term home parenteral nutrition (HPN), administered through a central venous catheter. Catheter-related bloodstream infection (CRBSI) with Staphylococcus aureus is known to be a serious infection with a high mortality rate and risk of complications. A standardized protocol on the management of S aureus CRBSIs in children receiving HPN is lacking. The aim of this study is to evaluate the effectiveness and safety of the current management in an HPN expertise center in the Netherlands.
We performed a retrospective descriptive cohort study between 2013 and 2022 on children 0-18 years of age with chronic IF requiring long-term HPN. Our primary outcomes were the incidence of S aureus CRBSI per 1000 catheter days, catheter salvage attempt rate, and successful catheter salvage rate. Our secondary outcomes included complications and mortality.
A total of 74 patients (39 male; 53%) were included, covering 327.8 catheter years. Twenty-eight patients (38%) had a total of 52 S aureus CRBSIs, with an incidence rate of 0.4 per 1000 catheter days. The catheter salvage attempt rate was 44% (23/52). The successful catheter salvage rate was 100%. No relapse occurred, and no removal was needed after catheter salvage. All complications that occurred were already present at admission before the decision to remove the catheter or not. No patients died because of an S aureus CRBSI.
Catheter salvage in S aureus CRBSIs in children receiving HPN can be attempted after careful consideration by a multidisciplinary team in an HPN expertise center.
患有慢性 IF 的儿童需要长期接受家庭肠外营养(HPN)治疗,通过中心静脉导管进行。金黄色葡萄球菌引起的导管相关血流感染(CRBSI)是一种严重的感染,死亡率和并发症风险较高。目前缺乏针对接受 HPN 的儿童金黄色葡萄球菌 CRBSI 管理的标准化方案。本研究旨在评估荷兰一家 HPN 专业中心目前管理方法的有效性和安全性。
我们对 2013 年至 2022 年间需要长期 HPN 的 0-18 岁慢性 IF 儿童进行了回顾性描述性队列研究。我们的主要结局指标是每 1000 个导管日金黄色葡萄球菌 CRBSI 的发生率、导管保留尝试率和导管保留成功率。我们的次要结局指标包括并发症和死亡率。
共纳入 74 例患者(39 名男性;53%),涵盖 327.8 个导管年。28 例患者(38%)共发生 52 例金黄色葡萄球菌 CRBSI,发生率为 0.4 例/1000 导管日。导管保留尝试率为 44%(23/52)。导管保留成功率为 100%。无一例复发,导管保留后无需再次移除。所有发生的并发症在决定是否移除导管之前已经存在。没有患者因金黄色葡萄球菌 CRBSI 而死亡。
在 HPN 专业中心,多学科团队在仔细考虑后可以尝试对接受 HPN 的儿童金黄色葡萄球菌 CRBSI 进行导管保留。